The recently published 8th version [1] of the AJCC melanoma classification introduces substantial changes in the melanoma prognostic categorization. Some of these variations have been criticized by a group of experts especially for the implications regarding the adjuvant treatments that became recently available [2]. One of the most relevant issues regards stage III as the new classification may impair the comparability of present and future adjuvant trials. Nevertheless, focusing on prognostic curves, even stage IIC is worth of attention. This article is protected by copyright. All rights reserved.

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?

Brancaccio, G;Napolitano, S;Troiani, T;Franco, R;Iovino, F;Reginelli, A;Ciardiello, F;Argenziano, G
2018

Abstract

The recently published 8th version [1] of the AJCC melanoma classification introduces substantial changes in the melanoma prognostic categorization. Some of these variations have been criticized by a group of experts especially for the implications regarding the adjuvant treatments that became recently available [2]. One of the most relevant issues regards stage III as the new classification may impair the comparability of present and future adjuvant trials. Nevertheless, focusing on prognostic curves, even stage IIC is worth of attention. This article is protected by copyright. All rights reserved.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11591/394639
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact